Everyday Bacteria on Verge of Becoming Antibiotic Resistant Superbugs
Published: 2015-03-28 - Updated: 2021-08-22
Author: Washington University School of Medicine | Contact: wustl.edu
Synopsis: Antibiotic resistance may spread globally among bacteria frequently implicated in respiratory and urinary infections in hospital settings. Drug resistant infections will kill an extra 10 million people a year worldwide - more than currently die from cancer - by 2050 unless action is taken. The study shows that two genes that confer resistance against a particularly strong class of antibiotics can be shared easily among a family of bacteria responsible for a significant portion of hospital-associated infections.
Antibiotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hospital settings, according to new research at Washington University School of Medicine in St. Louis.
The World Health Organization (WHO) defines antimicrobial resistance as a microorganism's resistance to an antimicrobial drug that was once able to treat an infection by that microorganism. A person cannot become resistant to antibiotics. Resistance is a property of the microbe, not the person or other organism infected by the microbe. Antimicrobial resistance (AMR) occurs when a microbe acquires a genetic mutation making it resistant to the effect of one or more antimicrobial agents that were once effective. This genetic mutation may be acquired spontaneously or by gene transfer. Bacteria can become resistant to antibiotics, for which the term antibiotic resistance is used. Microbes that are resistant to multiple antimicrobials are termed multi-drug resistant (MDR) (or, sometimes in the lay press, superbugs).
The study shows that two genes that confer resistance against a particularly strong class of antibiotics can be shared easily among a family of bacteria responsible for a significant portion of hospital-associated infections.
Drug-resistant germs in the same family of bacteria recently infected several patients at two Los Angeles hospitals.
The infections have been linked to medical scopes believed to have been contaminated with bacteria that can resist carbapenems, potent antibiotics that are supposed to be used only in gravely ill patients or those infected by resistant bacteria.
"Carbapenems are one of our last resorts for treating bacterial infections, what we use when nothing else works," said senior author Gautam Dantas, PhD, associate professor of pathology and immunology. "Given what we know now, I don't think it's overstating the case to say that for certain types of infections, we may be looking at the start of the post-antibiotic era, a time when most of the antibiotics we rely on to treat bacterial infections are no longer effective."
Dantas and other experts recommend strictly limiting the usage of carbapenems to cases in which no other treatments can help.
The study, conducted by researchers at Washington University, Barnes-Jewish Hospital and the National University of Sciences and Technology in Pakistan, is available online in Emerging Infectious Diseases.
The researchers studied a family of bacteria called Enterobacteriaceae, which includes E. coli, Klebsiella pneumoniae and Enterobacter.
Some strains of these bacteria do not cause illness and can help keep the body healthy. But in people with weakened immune systems, infections with carbapenem-resistant versions of these bacteria can be deadly.
The Centers for Disease Control and Prevention named carbapenem-resistant Enterobacteriaceae as one of the three most urgent threats among emerging forms of antibiotic-resistant disease.
Studies have shown the fatality rate for these infections is above 50 percent in patients with weakened immune systems.
Two genes are primarily responsible for carbapenem-resistant versions of these disease-causing bacteria.
One gene, KPC, was detected in New York in 2001 and quickly spread around most of the world, with the exception of India, Pakistan and other South Asian countries. This gene was present in the bacteria that recently contaminated medical equipment in a Los Angeles hospital where two patients died.
A second carbapenem resistance gene, NDM-1, was identified in 2006 in New Delhi, India. It was soon detected throughout South Asia, and most patients infected by bacteria with NDM-1 have had an epidemiological link to South Asian countries.
Dantas and his collaborators were curious about why the two resistance genes seemed to be geographically exclusive.
For the study, they compared the genomes of carbapenem-resistant bacteria isolated in the United States with those of carbapenem-resistant bacteria isolated in Pakistan.
Based on the apparent geographic exclusivity of the two resistance genes, the scientists expected to find that bacteria from the two regions were genetically different. Such differences could explain why the two resistance genes weren't intermingling. But the researchers' results showed otherwise. The bacteria's high genetic similarity suggests that the antibiotic resistance genes could be shared easily between bacteria from the two geographic regions.
The researchers also sequenced a special portion of bacterial genetic material called plasmids. Most of a bacteria's DNA is found in its chromosome, but bacteria also have many extra, smaller and circular bits of DNA known as plasmids that easily can pass from one bacterial strain to another. A plasmid is like a bacterial gene delivery truck; it is the primary way antibiotic resistance genes spread between bacteria.
The researchers identified a few key instances in which the plasmids carrying NDM-1 or KPC were nearly identical, meaning they easily could facilitate the spread of antibiotic resistance between disease-causing bacteria found in the United States and South Asia. Recent evidence suggests that this intermingling already may be happening in parts of China.
"Our findings also suggest it's going to get easier for strains of these bacteria that are not yet resistant to pick up a gene that lets them survive carbapenem treatment," Dantas said. "Typically, that's not going to be a problem for most of us, but as drug-resistant forms of Enterobacteriaceae become more widespread, the odds will increase that we'll pass one of these superbugs on to a friend with a weakened immune system who can really be hurt by them."
This research was supported by the National Institutes of Health (NIH) Director's New Innovator Award, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institute of General Medical Sciences, grant numbers DP2DK098089 and R01GM099538.
Pesesky MW, Hussain T, Wallace M, Wang B, Andleeb S, Burnham C-AD, Dantas G. KPC and NDM-1 are harbored by related Enterobacteriaceae strains and plasmid backbones form distinct geographies. Emerging Infectious Diseases, June 2015; dx.doi.org/10.3201/eid2106.141504.
Facts and Statistics
Drug resistant infections will kill an extra 10 million people a year worldwide - more than currently die from cancer - by 2050 unless action is taken, a study says. For the FY 2016 budget, President Obama has suggested to nearly double the amount of federal funding to "combat and prevent" antibiotic resistance to more than $1.2 billion. An April 30, 2014, report by WHO addressed ways people can help tackle resistance by:
- Using antibiotics only when prescribed by a doctor
- Completing the full prescription, even if they feel better
- Never sharing antibiotics with others or using leftover prescriptions
Health workers and pharmacists can help tackle resistance by:
- Enhancing infection prevention and control
- Prescribing and dispensing the right antibiotic(s) to treat the illness
- Only prescribing and dispensing antibiotics when they are truly needed
Policymakers can help tackle resistance by:
- Regulating and promoting appropriate use of medicines
- Strengthening resistance tracking and laboratory capacity
Policymakers and industry can help tackle resistance by:
- Fostering innovation and research and development of new tools
- Promoting cooperation and information sharing among all stakeholders
Primary Information Source(s):
Everyday Bacteria on Verge of Becoming Antibiotic Resistant Superbugs | Washington University School of Medicine (wustl.edu). Disabled World makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.
In Other News:
You're reading Disabled World. See our homepage for informative disability news, reviews, sports, stories and how-tos. You can also connect with us on social media such as Twitter and Facebook or learn more about Disabled World on our about us page.
Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
Cite This Page (APA): Washington University School of Medicine. (2015, March 28). Everyday Bacteria on Verge of Becoming Antibiotic Resistant Superbugs. Disabled World. Retrieved October 21, 2021 from www.disabled-world.com/health/bacteria-bugs.php